Discomfort and pain associated with the administration of vaccine products is likely a common reason why children and caregivers alike do not look forward to pediatric office visits.

Introduction:"Antipyretic Analgesics Market" Insights Report 2023 | Spread Across 101 Pages Report which provides an in-depth analysis Based on Regions, Applications (Adults, Children), and Types ...

Our Bureau, Mumbai Tuesday, July 22, 2025, 12:20 Hrs [IST] ...

The FDA has issued a final rule that requires manufacturers of over-the-counter (OTC) pain relievers and fever reducers to revise their labeling to include warnings about potential safety risks ...

Researchers have found that antibody levels do not drop among recipients of two COVID-19 vaccine shots who took antipyretic analgesics after experiencing adverse post-vaccination reactions.

That is, they all possess analgesic, anti-inflammatory and ANTIPYRETIC properties to some degree, and produce characteristic side effects, including gastric intolerance and depression of blood ...

Green Cross Corp. has released a new antipyretic analgesic. The medicine, Taksen 400 Ibuprofen, contains 400 milligrams of ibuprofen, an anti-inflammatory drug that is highly effective in reducing ...

Global Antipyretic Analgesics Market Growth (Status and Outlook) 2021-2026 presents a profound comprehension regarding the functioning and expansion of the market. The report contains a variety of ...